Perimeter Medical Imaging AI
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Perimeter Medical Imaging AI generated cash of -$14,696,253, which is less than the previous year. Cash used in financing activities reached the amount of $234,473 last year. Net change in cash is therefore -$14,458,872.
Cash Flow
| 2015 | -89.89K | 40.37K | 0 |
|---|---|---|---|
| 2017 | -79.64K | 144.31K | 0 |
| 2019 | -5.78M | -46.94K | 5.19M |
| 2020 | -8.26M | 7.23M | 9.83M |
| 2021 | -13.91M | -1.44M | 10.05M |
| 2022 | -11.86M | -1.74M | 40.28M |
| 2023 | -14.69M | 206.01K | 234.47K |
PINK.V Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | 2015 | |
|---|---|---|---|---|---|---|---|
Cash at beginning of period | 28.43M | 3.72M | 10.02M | 1.21M | 1.84M | 53.22K | 66.85K |
Operating activities | |||||||
Net income | -14.03M | -9.90M | -16.65M | -7.88M | -10.34M | 1.57M | -291.73K |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||
Depreciation and amortization | 614.70K | 800.86K | 93.83K | 47.57K | 51.83K | 0 | 0 |
Stock-based compensation expense | 1.46M | 1.52M | 2.48M | 1.76M | 1.32M | 0 | 0 |
| Deferred income tax benefit | 1.46M | 1.52M | 2.48M | 1.76M | 1.32M | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | -328.52K | -72K | 266.21K | 413.51K | -143.51K | 2.01K | -1.20K |
Inventories | -86.11K | -37.84K | -6.49K | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | -266.21K | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -14.69M | -11.86M | -13.91M | -8.26M | -5.78M | -79.64K | -89.89K |
Investing activities | |||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -474.50K | -1.99M | -2.12M | 0 | -46.94K | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 905.26K | 0 | 0 | 0 |
Cash generated by investing activities | 206.01K | -1.74M | -1.44M | 7.23M | -46.94K | 144.31K | 40.37K |
Financing activities | |||||||
Common Stock Issued | 0 | 38.13M | 10.25M | 9.40M | 3.12M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -284.84K | -227.08K | -204.40K | -141.08K | 1.68M | 0 | 0 |
Cash used in financing activities | 234.47K | 40.28M | 10.05M | 9.83M | 5.19M | 0 | 0 |
Net Change In Cash | -14.45M | 24.71M | -5.30M | 8.81M | -635.40K | 64.67K | -49.51K |
Cash at end of period | 13.98M | 28.43M | 4.72M | 10.02M | 1.21M | 117.9K | 17.33K |